Actively Recruiting
Evaluating Carbon Dioxide Effects on Brain Protein Movement and Waste Clearance in Adults With and Without Traumatic Brain Injury
Led by Andrew Mayer · Updated on 2026-10-06
200
Participants Needed
1
Research Sites
56 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how different levels of carbon dioxide CO2 exposure affect the movement of proteins from the brain into the blood. This movement may reflect the brains ability to clear waste products, which is important for people with traumatic brain injury TBI and other neurodegenerative conditions. The study uses a crossover design, including individuals with and without TBI, to test whether CO2 can safely increase brain waste clearance. Participants receive doses of CO2 to achieve targeted increases of about 5 or 10 mmHg in end-tidal CO2 during MRI scans. Each participant undergoes two visits spaced about one week apart, receiving different CO2 levels in random order without knowing the dose. This approach helps researchers understand how CO2 affects cerebrovascular function and protein efflux as a proxy for brain waste clearance. During the study, blood samples are taken at several times before and after CO2 exposure to measure protein levels. Advanced MRI techniques assess cerebrovascular reactivity and cerebrospinal fluid flow. Participants also report symptoms at various times after CO2 administration. Data will be analyzed after study completion to evaluate the effects and safety of CO2 dosing. The study includes adults aged 18 to 82 years and includes careful monitoring throughout the process.
CONDITIONS
Brief Title
Carbon Dioxide Administration and Brain Waste Clearance
Research Team
S
Sadie LaBauve, PhD
A
Andrew Mayer R The Mind Research Network, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here